Champions Oncology, Inc. (CSBR)

Champions Oncology Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Cash & Equivalents	9.79	2.62	10.12	9.01	4.69
Cash & Short-Term Investments	9.79	2.62	10.12	9.01	4.69
Cash Growth	273.76%	-74.13%	12.34%	92.17%	-43.81%
Receivables	11.23	9.53	8.01	9.51	6.99
Prepaid Expenses	1.35	1.5	1.33	1.14	0.96
Total Current Assets	22.37	13.64	19.46	19.66	12.63
Property, Plant & Equipment	9.46	11.97	14.5	15.36	14.61
Goodwill	0.34	0.34	0.34	0.34	0.34
Other Long-Term Assets	0.19	0.19	0.02	0.02	0.02
Total Assets	32.34	26.13	34.31	35.38	27.59
Accounts Payable	4.25	5.8	5.33	2.87	1.89
Accrued Expenses	2.56	2.16	2.27	2.41	2.23
Current Portion of Leases	1.61	1.34	1.21	1.05	0.82
Current Unearned Revenue	15.44	12.09	12.78	11.07	6.26
Other Current Liabilities	-	0.15	0.15	0.07	-
Total Current Liabilities	23.85	21.54	21.73	17.48	11.2
Long-Term Leases	4.72	6.09	7.39	8.41	8.78
Other Long-Term Liabilities	-	0.4	0.55	0.39	0.18
Total Liabilities	28.57	28.04	29.68	26.28	20.16
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	84.36	83.38	82.01	81.06	79.95
Retained Earnings	-79.89	-84.59	-77.32	-71.98	-72.53
Treasury Stock	-0.71	-0.71	-0.07	-	-
Shareholders' Equity	3.77	-1.9	4.64	9.1	7.43
Total Liabilities & Equity	32.34	26.13	34.31	35.38	27.59
Total Debt	6.33	7.43	8.6	9.47	9.6
Net Cash (Debt)	3.46	-4.81	1.52	-0.46	-4.91
Net Cash Per Share	0.24	-0.36	0.11	-0.03	-0.34
Filing Date Shares Outstanding	13.78	13.59	13.46	13.52	13.42
Total Common Shares Outstanding	13.78	13.59	13.54	13.52	13.41
Working Capital	-1.48	-7.9	-2.28	2.19	1.43
Book Value Per Share	0.27	-0.14	0.34	0.67	0.55
Tangible Book Value	3.44	-2.24	4.3	8.76	7.09
Tangible Book Value Per Share	0.25	-0.16	0.32	0.65	0.53
Machinery	12.73	12.9	11.74	9.82	8
Construction In Progress	0.12	0	1.08	0.18	1.21
Leasehold Improvements	0.32	0.32	0.11	0.11	0

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q